Marinus Pharmaceuticals Receives FDA Orphan Drug Designation for Ganaxolone
Marinus Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the development of innovative therapeutics to treat epilepsy and neuropsychiatric disorders, today announced that…
Read More...
Read More...
